{"id":22952,"date":"2026-09-24T11:56:40","date_gmt":"2026-09-24T09:56:40","guid":{"rendered":"https:\/\/mic-site.labiux.com\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/"},"modified":"2026-09-24T11:56:40","modified_gmt":"2026-09-24T09:56:40","slug":"valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/","title":{"rendered":"Valsts apmaks\u0101ti migr\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\u0146valst\u012bs l\u012bdz pat 20 rei\u017eu vair\u0101k"},"content":{"rendered":"<div class=\"wp-block-labiux-legacy-html legacy-content\">\n<p>\u0160oned\u0113\u013c pasaul\u0113 norisin\u0101s migr\u0113nas atpaz\u012bstam\u012bbas veicin\u0101\u0161anas ned\u0113\u013ca, kas piev\u0113r\u0161 uzman\u012bbu vienai no visbie\u017e\u0101k sastopamaj\u0101m, ta\u010du sabiedr\u012bb\u0101 joproj\u0101m nenov\u0113rt\u0113taj\u0101m neirolo\u0123iskaj\u0101m saslim\u0161an\u0101m. \u017durn\u0101l\u0101 The Lancet Neurology public\u0113ts p\u0113t\u012bjums liecina, ka migr\u0113na 2023. gad\u0101 pasaul\u0113 izrais\u012bjusi 40,9 miljonu vesel\u012bgas dz\u012bves gadu zudumu \u2013 r\u0101d\u012bt\u0101js, kas apvieno gan slimnieku skaitu, gan simptomu smagumu un ilgumu. Latvij\u0101 ar migr\u0113nu dz\u012bvo vair\u0101k nek\u0101 150 000 iedz\u012bvot\u0101ju, no kuriem liel\u0101k\u0101 da\u013ca ir sievietes darbsp\u0113jas vecuma. Neskatoties uz to, 2025. gada beig\u0101s modernu, valsts finans\u0113tu profilaktisko \u0101rst\u0113\u0161anu sa\u0146\u0113ma vien ap 200 pacientu. Kaimi\u0146valst\u012bs \u0161is skaitlis ir krietni augst\u0101ks. Igaunij\u0101 terapiju sa\u0146em vair\u0101k nek\u0101 800, Lietuv\u0101 \u2013 ap 3850 pacientu, lai gan migr\u0113nas izplat\u012bba Baltijas valst\u012bs b\u016btiski neat\u0161\u0137iras. \u0160\u012b gada vasar\u0101 \u0101rstu un pacientu organiz\u0101cijas nos\u016bt\u012bja atkl\u0101tu v\u0113stuli Vesel\u012bbas ministrijai un Nacion\u0101lajam vesel\u012bbas dienestam, aicinot uzs\u0101kt sarunu par medikamentu pieejam\u012bbas uzlabo\u0161anu, ta\u010du atbildes l\u012bdz \u0161im nav sekoju\u0161as.<\/p>\n<p><strong>Kas ir migr\u0113na?<\/strong><\/p>\n<p>Migr\u0113na nav vienk\u0101r\u0161i galvass\u0101pes. T\u0101 ir hroniska neirolo\u0123iska slim\u012bba ar vid\u0113ji smag\u0101m, smag\u0101m vai pat nepanesam\u0101m s\u0101pju l\u0113km\u0113m, kur\u0101m bie\u017ei pievienojas slikta d\u016b\u0161a, vem\u0161ana, gaismas un ska\u0146as paaugstin\u0101ta jut\u012bba, da\u017ek\u0101rt ar\u012b p\u0101rejo\u0161i redzes trauc\u0113jumi. Pasaul\u0113 migr\u0113na ir otrais bie\u017e\u0101kais darbnesp\u0113jas iemesls kopum\u0101 un pirmais \u2013 jaunu sievie\u0161u vid\u016b. Slim\u012bba visvair\u0101k skar tie\u0161i tos cilv\u0113kus, no kuriem atkar\u012bga valsts ekonomika un demogr\u0101fisk\u0101 n\u0101kotne: str\u0101d\u0101jo\u0161os, vec\u0101kus, \u0123ime\u0146u apg\u0101dniekus. Hroniskas formas gad\u012bjum\u0101 l\u0113kmes var atk\u0101rtoties vair\u0101k nek\u0101 15 reizes m\u0113nes\u012b, spie\u017eot cilv\u0113kus pamest darbu vai m\u0101c\u012bbas, bet bez ties\u012bb\u0101m uz invalidit\u0101tes pabalstu.<\/p>\n<p>Katra l\u0113kme noz\u012bm\u0113 zaud\u0113tu darba dienu, izlaistus soci\u0101los notikumus un nep\u0101rtrauktu trauksmi par to, kad slim\u012bba atkal pieteiksies. Daudziem pacientiem gadu no gada n\u0101kas dz\u012bvot cer\u012bb\u0101, ka n\u0101kam\u0101 izm\u0113\u0123in\u0101t\u0101 \u0101rst\u0113\u0161ana beidzot iedarbosies. Kam\u0113r cit\u0101m hronisk\u0101m slim\u012bb\u0101m sabiedr\u012bba izr\u0101da izpratni, migr\u0113nas slimniekiem joproj\u0101m bie\u017ei atg\u0101dina, ka t\u0101s esot \u201ctikai galvass\u0101pes\u201d \u2013 \u0161\u0101da attieksme kav\u0113 cilv\u0113kus laikus v\u0113rsties p\u0113c pal\u012bdz\u012bbas. Ierobe\u017eot\u0101 piek\u013cuve efekt\u012bvai terapijai vienlaikus veicina p\u0101rm\u0113r\u012bgu bezrecep\u0161u prets\u0101pju l\u012bdzek\u013cu lieto\u0161anu, kas var izrais\u012bt gan no medikamentiem atkar\u012bgas galvass\u0101pes, gan nopietnus aknu, nieru un ku\u0146\u0123a-zarnu trakta boj\u0101jumus.<\/p>\n<p><strong>\u0100rst\u0113\u0161anas pieejam\u012bba Latvij\u0101<\/strong><\/p>\n<p>Valsts kompens\u0113 profilaktisko terapiju vien\u012bgi pacientiem ar hronisku migr\u0113nu, proti, tiem, kam l\u0113kmes atk\u0101rtojas vair\u0101k nek\u0101 15 dienas m\u0113nes\u012b. Lai medikamentu visp\u0101r var\u0113tu sa\u0146emt, \u0101rstam j\u0101apstiprina, ka devi\u0146u m\u0113ne\u0161u laik\u0101 nav g\u016bts rezult\u0101ts ar trim at\u0161\u0137ir\u012bg\u0101m profilaktisko medikamentu grup\u0101m. Papildus nepiecie\u0161ams neirologu-algologu kons\u012blijs, kas norisin\u0101s vien da\u017e\u0101s liel\u0101s slimn\u012bcas. Tas noz\u012bm\u0113 v\u0113l vienu rindu uz neirologa viz\u012bti valsts kvotu ietvaros un iev\u0113rojamu administrat\u012bvo slogu gan pacientam, gan \u0101rstam. Da\u013ca pacientu \u0161o garo procesu neiziet l\u012bdz galam, jo nesagaida nedz s\u0101pju atvieglojumu no jau noz\u012bm\u0113tajiem medikamentiem, nedz rindu pie speci\u0101lista.<\/p>\n<p>J\u016blij\u0101 Latvijas Neirologu biedr\u012bba, Paula Stradi\u0146a Kl\u012bnisk\u0101s universit\u0101tes slimn\u012bcas S\u0101pju apr\u016bpes noda\u013ca, R\u012bgas Austrumu kl\u012bnisk\u0101s universit\u0101tes slimn\u012bcas \u201cGai\u013cezers\u201d Galvass\u0101pju vien\u012bba, Migr\u0113nas pacientu biedr\u012bba un Latvijas Sievie\u0161u nevalstisko organiz\u0101ciju sadarb\u012bbas t\u012bkls kop\u012bgi v\u0113rs\u0101s pie Vesel\u012bbas ministrijas un Nacion\u0101l\u0101 vesel\u012bbas dienesta ar aicin\u0101jumu p\u0101rskat\u012bt migr\u0113nas medikamentu kompens\u0101cijas k\u0101rt\u012bbu. Lai gan jaut\u0101jums skar iev\u0113rojamu da\u013cu Latvijas iedz\u012bvot\u0101ju un ietekm\u0113 valsts darbasp\u0113ka vesel\u012bbu, atbilde uz v\u0113stuli joproj\u0101m nav sa\u0146emta.<\/p>\n<p>\u201cDaudzviet Eirop\u0101 kompens\u0113ta terapija pacientam pieejama jau p\u0113c viena vai diviem neveiksm\u012bgiem nespecifiskiem profilaktisk\u0101s terapijas m\u0113\u0123in\u0101jumiem, un Latvija ir viena no retaj\u0101m valst\u012bm, kur l\u0113mums par t\u0101s noz\u012bm\u0113\u0161anu ir pak\u013cauts oblig\u0101tam kons\u012blijam. Tas ir paradoks\u0101li, jo \u0161o terapiju k\u0101 pirm\u0101s izv\u0113les \u0101rst\u0113\u0161anu pacientiem ar vismaz \u010detr\u0101m migr\u0113nas dien\u0101m m\u0113nes\u012b rekomend\u0113 gan Eiropas Galvass\u0101pju feder\u0101cija, gan Starptautisk\u0101 Galvass\u0101pju biedr\u012bba. \u0160obr\u012bd pieeju efekt\u012bvai migr\u0113nas \u0101rst\u0113\u0161anai Latvij\u0101 vair\u0101k nosaka administrat\u012bvie ierobe\u017eojumi nek\u0101 m\u016bsdienu medic\u012bnas iesp\u0113jas \u2013 un tie\u0161i \u0161o neatbilst\u012bbu m\u0113s aicin\u0101m vald\u012bbu risin\u0101t,\u201d iez\u012bm\u0113 neirolo\u0123e, algolo\u0123e, <strong>L\u012bga Mek\u0161a<\/strong>.<\/p>\n<p>Situ\u0101ciju papildus apgr\u016btina tas, ka Latvij\u0101 tr\u016bkst specializ\u0113tu galvass\u0101pju centru un tajos str\u0101d\u0101jo\u0161u speci\u0101listu. Vienlaikus arvien vair\u0101k pacientu p\u0113c ilgsto\u0161as neskaidr\u012bbas beidzot sa\u0146em pareizu diagnozi, ta\u010du non\u0101k sist\u0113m\u0101, kas nesp\u0113j nodro\u0161in\u0101t savlaic\u012bgu pal\u012bdz\u012bbu. T\u0101 veidojas apburtais loks. Jo ilg\u0101k pacients gaida uz m\u016bsdien\u012bgu profilaktisko terapiju, jo liel\u0101ka iesp\u0113ja, ka migr\u0113na k\u013c\u016bst hroniska, bet \u0101rst\u0113\u0161ana \u2013 sare\u017e\u0123\u012bt\u0101ka un d\u0101rg\u0101ka.<\/p>\n<p><strong>Ierosin\u0101t\u0101s izmai\u0146as:<\/strong><\/p>\n<p>\u2022 Likvid\u0113t oblig\u0101to \u0101rstu kons\u012bliju. \u0160obr\u012bd kons\u012blijus dr\u012bkst r\u012bkot vien da\u017eas slimn\u012bcas, kas rada papildu birokr\u0101tiju un pagarina ce\u013cu l\u012bdz \u0101rst\u0113\u0161anai. Pacientam svar\u012bg\u0101k ir \u0101tri nok\u013c\u016bt pie \u0101rsta, kas sp\u0113j noz\u012bm\u0113t atbilsto\u0161u terapiju. Lielo slimn\u012bcu galvass\u0101pju centros b\u016btu j\u0101ievie\u0161 ar\u012b pacientu atbalsta funkcija \u2013 piem\u0113ram, koordinators vai galvass\u0101pju apr\u016bpes m\u0101sa, kas pal\u012bdz\u0113tu pacientiem orient\u0113ties sist\u0113m\u0101 un nepazust rind\u0101s.<\/p>\n<p>\u2022 Sa\u012bsin\u0101t ce\u013cu l\u012bdz valsts apmaks\u0101tiem medikamentiem. Tas noz\u012bm\u0113 samazin\u0101t gan to profilaktisko medikamentu skaitu, kas j\u0101izm\u0113\u0123ina pirms kompens\u0113jam\u0101s terapijas, gan laiku, cik ilgi katrs no tiem j\u0101lieto.<\/p>\n<p>\u201cMigr\u0113nas rad\u012bto slogu ir gr\u016bti piln\u012bb\u0101 izprast, ja ar \u0161o slim\u012bbu nav n\u0101cies saskarties pa\u0161am vai k\u0101dam tuviniekam. V\u0113stul\u0113 izvirz\u012bj\u0101m konkr\u0113tus priek\u0161likumus, kas pal\u012bdz\u0113tu vienk\u0101r\u0161ot pacienta ce\u013cu l\u012bdz \u0101rst\u0113\u0161anai un uzlabot efekt\u012bvas profilaktisk\u0101s terapijas pieejam\u012bbu pacientiem ar bie\u017e\u0101m migr\u0113nas l\u0113km\u0113m. L\u012bdz \u0161im uz \u0161o v\u0113stuli atbildi neesam sa\u0146\u0113mu\u0161i. Tikm\u0113r pacientiem \u0161ie jaut\u0101jumi nav k\u013cuvu\u0161i maz\u0101k aktu\u0101li. Joproj\u0101m ir cilv\u0113ki, kuri migr\u0113nas d\u0113\u013c nesp\u0113j pilnv\u0113rt\u012bgi str\u0101d\u0101t, r\u016bp\u0113ties par \u0123imeni un dz\u012bvot ierasto dz\u012bvi. T\u0101p\u0113c atk\u0101rtoti aicin\u0101m Vesel\u012bbas ministriju un Nacion\u0101lo vesel\u012bbas dienestu atsaukties uz m\u016bsu iepriek\u0161 pausto l\u016bgumu uzs\u0101kt konstrukt\u012bvu sarunu. M\u0113s esam gatavi run\u0101t, sniegt pacientu perspekt\u012bvu, nepiecie\u0161amo inform\u0101ciju un kop\u0101 mekl\u0113t praktiskus risin\u0101jumus, kas uzlabotu migr\u0113nas pacientu \u0101rst\u0113\u0161anas pieejam\u012bbu Latvij\u0101,\u201d iez\u012bm\u0113 <strong>Daina \u0112ce<\/strong>, Migr\u0113nas pacientu biedr\u012bbas p\u0101rst\u0101ve.<\/p>\n<p>Lab\u0101ka migr\u0113nas \u0101rst\u0113\u0161anas pieejam\u012bba nav \u0161aura pacientu grupas interese. T\u0101 ir ieguld\u012bjums Latvijas iedz\u012bvot\u0101ju darbsp\u0113j\u0101, vesel\u012bbas apr\u016bpes sist\u0113mas ilgtermi\u0146a noslodzes mazin\u0101\u0161an\u0101 un m\u016bsdien\u012bgu \u0101rst\u0113\u0161anas standartu nodro\u0161in\u0101\u0161an\u0101. Diagnostic\u0113to migr\u0113nas pacientu skaits Latvij\u0101 ik gadu pieaug, t\u0101p\u0113c ar\u012b piepras\u012bjums p\u0113c efekt\u012bvas terapijas n\u0101kotn\u0113 tikai augs. Migr\u0113nas izpratnes ned\u0113\u013ca atg\u0101dina, ka aiz \u0161\u012bs slim\u012bbas sl\u0113pjas ne tikai individu\u0101las cie\u0161anas, bet ar\u012b zaud\u0113ts darbasp\u0113ks un neizmantots \u0101rst\u0113\u0161anas potenci\u0101ls. \u0100rsti un pacienti cer, ka Vesel\u012bbas ministrija un Nacion\u0101lais vesel\u012bbas dienests beidzot atsauksies uz vasar\u0101 pausto aicin\u0101jumu un uzs\u0101ks dialogu par migr\u0113nas \u0101rst\u0113\u0161anas pieejam\u012bbas uzlabo\u0161anu Latvij\u0101.<\/p>\n<p>Avots: LETA<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u0160oned\u0113\u013c pasaul\u0113 norisin\u0101s migr\u0113nas atpaz\u012bstam\u012bbas veicin\u0101\u0161anas ned\u0113\u013ca, kas piev\u0113r\u0161 uzman\u012bbu vienai no visbie\u017e\u0101k sastopamaj\u0101m, ta\u010du sabiedr\u012bb\u0101 joproj\u0101m nenov\u0113rt\u0113taj\u0101m neirolo\u0123iskaj\u0101m saslim\u0161an\u0101m. \u017durn\u0101l\u0101 The Lancet Neurology public\u0113ts p\u0113t\u012bjums liecina, ka migr\u0113na 2023. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":13211,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[76,214],"tags":[342],"mic_flag":[],"class_list":["post-22952","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunakie-raksti","category-spec-vied","tag-migrena"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"\u0160oned\u0113\u013c pasaul\u0113 norisin\u0101s migr\u0113nas atpaz\u012bstam\u012bbas veicin\u0101\u0161anas ned\u0113\u013ca, kas piev\u0113r\u0161 uzman\u012bbu vienai no visbie\u017e\u0101k sastopamaj\u0101m, ta\u010du sabiedr\u012bb\u0101 joproj\u0101m nenov\u0113rt\u0113taj\u0101m neirolo\u0123iskaj\u0101m saslim\u0161an\u0101m. \u017durn\u0101l\u0101 The Lancet Neurology public\u0113ts p\u0113t\u012bjums liecina, ka migr\u0113na 2023. gad\u0101 pasaul\u0113 izrais\u012bjusi 40,9 miljonu vesel\u012bgas dz\u012bves gadu zudumu \u2013 r\u0101d\u012bt\u0101js, kas apvieno gan slimnieku skaitu, gan simptomu smagumu un ilgumu. Latvij\u0101 ar migr\u0113nu dz\u012bvo\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Valsts apmaks\u0101ti migr\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\u0146valst\u012bs l\u012bdz pat 20 rei\u017eu vair\u0101k - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"\u0160oned\u0113\u013c pasaul\u0113 norisin\u0101s migr\u0113nas atpaz\u012bstam\u012bbas veicin\u0101\u0161anas ned\u0113\u013ca, kas piev\u0113r\u0161 uzman\u012bbu vienai no visbie\u017e\u0101k sastopamaj\u0101m, ta\u010du sabiedr\u012bb\u0101 joproj\u0101m nenov\u0113rt\u0113taj\u0101m neirolo\u0123iskaj\u0101m saslim\u0161an\u0101m. \u017durn\u0101l\u0101 The Lancet Neurology public\u0113ts p\u0113t\u012bjums liecina, ka migr\u0113na 2023. gad\u0101 pasaul\u0113 izrais\u012bjusi 40,9 miljonu vesel\u012bgas dz\u012bves gadu zudumu \u2013 r\u0101d\u012bt\u0101js, kas apvieno gan slimnieku skaitu, gan simptomu smagumu un ilgumu. Latvij\u0101 ar migr\u0113nu dz\u012bvo\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2021\/08\/migraine-relief.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2021\/08\/migraine-relief.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"850\" \/>\n\t\t<meta property=\"og:image:height\" content=\"425\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-09-24T09:56:40+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-09-24T09:56:40+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Valsts apmaks\u0101ti migr\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\u0146valst\u012bs l\u012bdz pat 20 rei\u017eu vair\u0101k - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"\u0160oned\u0113\u013c pasaul\u0113 norisin\u0101s migr\u0113nas atpaz\u012bstam\u012bbas veicin\u0101\u0161anas ned\u0113\u013ca, kas piev\u0113r\u0161 uzman\u012bbu vienai no visbie\u017e\u0101k sastopamaj\u0101m, ta\u010du sabiedr\u012bb\u0101 joproj\u0101m nenov\u0113rt\u0113taj\u0101m neirolo\u0123iskaj\u0101m saslim\u0161an\u0101m. \u017durn\u0101l\u0101 The Lancet Neurology public\u0113ts p\u0113t\u012bjums liecina, ka migr\u0113na 2023. gad\u0101 pasaul\u0113 izrais\u012bjusi 40,9 miljonu vesel\u012bgas dz\u012bves gadu zudumu \u2013 r\u0101d\u012bt\u0101js, kas apvieno gan slimnieku skaitu, gan simptomu smagumu un ilgumu. Latvij\u0101 ar migr\u0113nu dz\u012bvo\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2021\/08\/migraine-relief.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/jaunakie-raksti\\\/#listItem\",\"name\":\"Jaun\\u0101kie raksti\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/jaunakie-raksti\\\/#listItem\",\"position\":2,\"name\":\"Jaun\\u0101kie raksti\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/jaunakie-raksti\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\\\/#listItem\",\"name\":\"Valsts apmaks\\u0101ti migr\\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\\u0146valst\\u012bs l\\u012bdz pat 20 rei\\u017eu vair\\u0101k\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\\\/#listItem\",\"position\":3,\"name\":\"Valsts apmaks\\u0101ti migr\\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\\u0146valst\\u012bs l\\u012bdz pat 20 rei\\u017eu vair\\u0101k\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/jaunakie-raksti\\\/#listItem\",\"name\":\"Jaun\\u0101kie raksti\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\\\/#newsarticle\",\"name\":\"Valsts apmaks\\u0101ti migr\\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\\u0146valst\\u012bs l\\u012bdz pat 20 rei\\u017eu vair\\u0101k - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"Valsts apmaks\\u0101ti migr\\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\\u0146valst\\u012bs l\\u012bdz pat 20 rei\\u017eu vair\\u0101k\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/migraine-relief.jpg\",\"width\":850,\"height\":425},\"datePublished\":\"2026-09-24T11:56:40+03:00\",\"dateModified\":\"2026-09-24T11:56:40+03:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\\\/#webpage\"},\"articleSection\":\"Jaun\\u0101kie raksti, Speci\\u0101lista viedoklis, migr\\u0113na\",\"dateline\":\"Published on September 24, 2026.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\\\/\",\"name\":\"Valsts apmaks\\u0101ti migr\\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\\u0146valst\\u012bs l\\u012bdz pat 20 rei\\u017eu vair\\u0101k - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"\\u0160oned\\u0113\\u013c pasaul\\u0113 norisin\\u0101s migr\\u0113nas atpaz\\u012bstam\\u012bbas veicin\\u0101\\u0161anas ned\\u0113\\u013ca, kas piev\\u0113r\\u0161 uzman\\u012bbu vienai no visbie\\u017e\\u0101k sastopamaj\\u0101m, ta\\u010du sabiedr\\u012bb\\u0101 joproj\\u0101m nenov\\u0113rt\\u0113taj\\u0101m neirolo\\u0123iskaj\\u0101m saslim\\u0161an\\u0101m. \\u017durn\\u0101l\\u0101 The Lancet Neurology public\\u0113ts p\\u0113t\\u012bjums liecina, ka migr\\u0113na 2023. gad\\u0101 pasaul\\u0113 izrais\\u012bjusi 40,9 miljonu vesel\\u012bgas dz\\u012bves gadu zudumu \\u2013 r\\u0101d\\u012bt\\u0101js, kas apvieno gan slimnieku skaitu, gan simptomu smagumu un ilgumu. Latvij\\u0101 ar migr\\u0113nu dz\\u012bvo\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/migraine-relief.jpg\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\\\/#mainImage\",\"width\":850,\"height\":425},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\\\/#mainImage\"},\"datePublished\":\"2026-09-24T11:56:40+03:00\",\"dateModified\":\"2026-09-24T11:56:40+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Valsts apmaks\u0101ti migr\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\u0146valst\u012bs l\u012bdz pat 20 rei\u017eu vair\u0101k - Medikamentu Inform\u0101cijas Centrs","description":"\u0160oned\u0113\u013c pasaul\u0113 norisin\u0101s migr\u0113nas atpaz\u012bstam\u012bbas veicin\u0101\u0161anas ned\u0113\u013ca, kas piev\u0113r\u0161 uzman\u012bbu vienai no visbie\u017e\u0101k sastopamaj\u0101m, ta\u010du sabiedr\u012bb\u0101 joproj\u0101m nenov\u0113rt\u0113taj\u0101m neirolo\u0123iskaj\u0101m saslim\u0161an\u0101m. \u017durn\u0101l\u0101 The Lancet Neurology public\u0113ts p\u0113t\u012bjums liecina, ka migr\u0113na 2023. gad\u0101 pasaul\u0113 izrais\u012bjusi 40,9 miljonu vesel\u012bgas dz\u012bves gadu zudumu \u2013 r\u0101d\u012bt\u0101js, kas apvieno gan slimnieku skaitu, gan simptomu smagumu un ilgumu. Latvij\u0101 ar migr\u0113nu dz\u012bvo","canonical_url":"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/#listItem","name":"Jaun\u0101kie raksti"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/#listItem","position":2,"name":"Jaun\u0101kie raksti","item":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/#listItem","name":"Valsts apmaks\u0101ti migr\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\u0146valst\u012bs l\u012bdz pat 20 rei\u017eu vair\u0101k"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/#listItem","position":3,"name":"Valsts apmaks\u0101ti migr\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\u0146valst\u012bs l\u012bdz pat 20 rei\u017eu vair\u0101k","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/#listItem","name":"Jaun\u0101kie raksti"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/#newsarticle","name":"Valsts apmaks\u0101ti migr\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\u0146valst\u012bs l\u012bdz pat 20 rei\u017eu vair\u0101k - Medikamentu Inform\u0101cijas Centrs","headline":"Valsts apmaks\u0101ti migr\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\u0146valst\u012bs l\u012bdz pat 20 rei\u017eu vair\u0101k","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2021\/08\/migraine-relief.jpg","width":850,"height":425},"datePublished":"2026-09-24T11:56:40+03:00","dateModified":"2026-09-24T11:56:40+03:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/#webpage"},"articleSection":"Jaun\u0101kie raksti, Speci\u0101lista viedoklis, migr\u0113na","dateline":"Published on September 24, 2026."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/","name":"Valsts apmaks\u0101ti migr\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\u0146valst\u012bs l\u012bdz pat 20 rei\u017eu vair\u0101k - Medikamentu Inform\u0101cijas Centrs","description":"\u0160oned\u0113\u013c pasaul\u0113 norisin\u0101s migr\u0113nas atpaz\u012bstam\u012bbas veicin\u0101\u0161anas ned\u0113\u013ca, kas piev\u0113r\u0161 uzman\u012bbu vienai no visbie\u017e\u0101k sastopamaj\u0101m, ta\u010du sabiedr\u012bb\u0101 joproj\u0101m nenov\u0113rt\u0113taj\u0101m neirolo\u0123iskaj\u0101m saslim\u0161an\u0101m. \u017durn\u0101l\u0101 The Lancet Neurology public\u0113ts p\u0113t\u012bjums liecina, ka migr\u0113na 2023. gad\u0101 pasaul\u0113 izrais\u012bjusi 40,9 miljonu vesel\u012bgas dz\u012bves gadu zudumu \u2013 r\u0101d\u012bt\u0101js, kas apvieno gan slimnieku skaitu, gan simptomu smagumu un ilgumu. Latvij\u0101 ar migr\u0113nu dz\u012bvo","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2021\/08\/migraine-relief.jpg","@id":"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/#mainImage","width":850,"height":425},"primaryImageOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/#mainImage"},"datePublished":"2026-09-24T11:56:40+03:00","dateModified":"2026-09-24T11:56:40+03:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"Valsts apmaks\u0101ti migr\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\u0146valst\u012bs l\u012bdz pat 20 rei\u017eu vair\u0101k - Medikamentu Inform\u0101cijas Centrs","og:description":"\u0160oned\u0113\u013c pasaul\u0113 norisin\u0101s migr\u0113nas atpaz\u012bstam\u012bbas veicin\u0101\u0161anas ned\u0113\u013ca, kas piev\u0113r\u0161 uzman\u012bbu vienai no visbie\u017e\u0101k sastopamaj\u0101m, ta\u010du sabiedr\u012bb\u0101 joproj\u0101m nenov\u0113rt\u0113taj\u0101m neirolo\u0123iskaj\u0101m saslim\u0161an\u0101m. \u017durn\u0101l\u0101 The Lancet Neurology public\u0113ts p\u0113t\u012bjums liecina, ka migr\u0113na 2023. gad\u0101 pasaul\u0113 izrais\u012bjusi 40,9 miljonu vesel\u012bgas dz\u012bves gadu zudumu \u2013 r\u0101d\u012bt\u0101js, kas apvieno gan slimnieku skaitu, gan simptomu smagumu un ilgumu. Latvij\u0101 ar migr\u0113nu dz\u012bvo","og:url":"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/","og:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2021\/08\/migraine-relief.jpg","og:image:secure_url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2021\/08\/migraine-relief.jpg","og:image:width":850,"og:image:height":425,"article:published_time":"2026-09-24T09:56:40+00:00","article:modified_time":"2026-09-24T09:56:40+00:00","twitter:card":"summary_large_image","twitter:title":"Valsts apmaks\u0101ti migr\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\u0146valst\u012bs l\u012bdz pat 20 rei\u017eu vair\u0101k - Medikamentu Inform\u0101cijas Centrs","twitter:description":"\u0160oned\u0113\u013c pasaul\u0113 norisin\u0101s migr\u0113nas atpaz\u012bstam\u012bbas veicin\u0101\u0161anas ned\u0113\u013ca, kas piev\u0113r\u0161 uzman\u012bbu vienai no visbie\u017e\u0101k sastopamaj\u0101m, ta\u010du sabiedr\u012bb\u0101 joproj\u0101m nenov\u0113rt\u0113taj\u0101m neirolo\u0123iskaj\u0101m saslim\u0161an\u0101m. \u017durn\u0101l\u0101 The Lancet Neurology public\u0113ts p\u0113t\u012bjums liecina, ka migr\u0113na 2023. gad\u0101 pasaul\u0113 izrais\u012bjusi 40,9 miljonu vesel\u012bgas dz\u012bves gadu zudumu \u2013 r\u0101d\u012bt\u0101js, kas apvieno gan slimnieku skaitu, gan simptomu smagumu un ilgumu. Latvij\u0101 ar migr\u0113nu dz\u012bvo","twitter:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2021\/08\/migraine-relief.jpg"},"aioseo_meta_data":{"post_id":"22952","title":null,"description":null,"keywords":null,"keyphrases":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-10-16 20:55:05","updated":"2026-10-16 20:55:05"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/\" title=\"Jaun\u0101kie raksti\">Jaun\u0101kie raksti<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tValsts apmaks\u0101ti migr\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\u0146valst\u012bs l\u012bdz pat 20 rei\u017eu vair\u0101k\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"Jaun\u0101kie raksti","link":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/"},{"label":"Valsts apmaks\u0101ti migr\u0113nas medikamenti pieejami tikai 0,13% pacientu. Kaimi\u0146valst\u012bs l\u012bdz pat 20 rei\u017eu vair\u0101k","link":"https:\/\/farmacija-mic.lv\/en\/valsts-apmaksati-migrenas-medikamenti-pieejami-tikai-013-pacientu-kaiminvalstis-lidz-pat-20-reizu\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/22952","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=22952"}],"version-history":[{"count":0,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/22952\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media\/13211"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=22952"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=22952"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=22952"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=22952"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}